Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 03/04/2015 (Notice of voluntarily dismissal)

Filing Date: December 18, 2013

Teva Pharmaceutical Industries Ltd. ("Teva" or the Company) is an Israeli multinational pharmaceutical company that specializes primarily in generic drugs.

According to the Complaint, it is alleged that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business and operations. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that there was significant internal discord between the Board and Teva' s senior management during the Class Period (and in particular, significant differences between the Chairman of the Board and the CEO) concerning execution of the Company's strategies, including implementation of the critical Cost Cutting Program. As a result of the foregoing, the Company's stock traded at artificially inflated prices during the Class Period.

On July 8, 2014, an amended Complaint was filed.

On July 16, 2014, the Court issued an Order appointing lead Plaintiff and approving lead Counsel.

This case was voluntarily dismissed on March 4, 2015.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.